nach oben

Diabetologia

Erschienen in:

01.10.2006 | Review

Type 2 diabetes and cardiovascular risk in the UK south Asian community

verfasst von: A. H. Barnett, A. N. Dixon, S. Bellary, M. W. Hanif, J. P. O’Hare, N. T. Raymond, S. Kumar

Erschienen in: Diabetologia | Ausgabe 10/2006

Einloggen, um Zugang zu erhalten

Abstract

A popular hypothesis for the greater prevalence of type 2 diabetes and cardiovascular disease in UK south Asians is that they have an increased susceptibility of developing insulin resistance in response to certain environmental factors, including obesity and adoption of a sedentary lifestyle. Insulin resistance is postulated as a central feature of the metabolic syndrome, culminating in type 2 diabetes, atherosclerotic vascular disease and CHD; a pathway potentially accelerated by migration/urbanisation. We describe and compare the prevalence of type 2 diabetes, cardiovascular disease and their associated risk factors in UK south Asian and white Caucasian populations to determine possible reasons for the increased preponderance of these diseases in south Asians, and highlight key evidence for optimal risk factor management. Finally, we describe a UK community-based programme that attempts to reduce the morbidity and mortality from type 2 diabetes and cardiovascular disease in south Asians through a new approach to management.

Office for National Statistics (2001) 2001 Census. Available from http://www.statistics.gov.uk/, last accessed May 2006

Cappuccio FP, Cook DG, Atkinson RW, Wicks PD (1998) The Wandsworth heart and stroke study. A population-based survey of cardiovascular risk factors in different ethnic groups. Methods and baseline findings. Nutr Metab Cardiovasc Dis 8:371–385

Jenum AK, Holme I, Graff-Iversen S, Birkeland KI (2005) Ethnicity and sex are strong determinants of diabetes in an urban Western society: implications for prevention. Diabetologia 48:435–439PubMedCrossRef

McKeigue PM, Shah B, Marmot MG (1991) Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 337:382–386PubMedCrossRef

McKeigue PM, Ferrie JE, Pierpoint T, Marmot MG (1993) Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinaemia. Circulation 87:152–161PubMed

Mohanty SA, Woolhandler S, Himmelstein DU, Bor DH (2005) Diabetes and cardiovascular disease among Asian Indians in the United States. J Gen Intern Med 20:474–488PubMedCrossRef

Anand SS, Yusuf S, Vuksan V et al (2000) Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 356:279–284PubMedCrossRef

Balarajan R (1991) Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales. BMJ 302:560–564PubMed

McKeigue PM, Marmot MG (1988) Mortality from coronary heart disease in Asian communities in London. BMJ 297:903PubMed

10.

Wild S, McKeigue P (1997) Cross sectional analysis of mortality by country of birth in England and Wales, 1970–92. BMJ 314:705PubMed

11.

UK Prospective Diabetes Study Group (1998) Ethnicity and cardiovascular disease. The incidence of myocardial infarction in white, South Asian, and Afro-Caribbean patients with type 2 diabetes (UK Prospective Diabetes Study 32). Diabetes Care 21:1271–1277CrossRef

12.

Woodward M, Zhang X, Barzi F et al (2003) The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. Diabetes Care 26:360–366PubMedCrossRef

13.

Fischbacher CM, Bhopal R, Rutter MK et al (2003) Microalbuminuria is more frequent in South Asian than in European origin populations: a comparative study in Newcastle, UK. Diabet Med 20:31–36PubMedCrossRef

14.

Mather HM, Keen H (1985) The Southall Diabetes Survey: prevalence of known diabetes in Asians and Europeans. Br Med J (Clin Res Ed) 291:1081–1084

15.

Simmons D, Williams DR, Powell MJ (1989) Prevalence of diabetes in a predominantly Asian community: preliminary findings of the Coventry Diabetes Study. BMJ 298:18–21PubMed

16.

Health Survey for England (2001) The health of minority ethnic groups ’99. The Stationery Office, London

17.

UK Prospective Diabetes Study Group (1994) UK Prospective Diabetes Study XII: differences between Asian, Afro-Caribbean and white Caucasian type 2 diabetic patients at diagnosis of diabetes. Diabet Med 11:670–677CrossRef

18.

Bodansky HJ, Staines A, Stephenson C et al (1992) Evidence for an environmental effect in the aetiology of insulin dependent diabetes in a transmigratory population. BMJ 304:1020–1022PubMedCrossRef

19.

Staines A, Hanif S, Ahmed S et al (1997) The incidence of insulin dependent diabetes mellitus in Karachi, Pakistan. Arch Dis Child 76:121–123PubMed

20.

Feltbower RG, Bodansky HJ, McKinney PA et al (2002) Trends in the incidence of type 1 diabetes in south Asians and other children in Bradford, UK. Diabet Med 19:162–166PubMedCrossRef

21.

Chaturvedi N, Fuller JH (1996) Ethnic differences in mortality from cardiovascular disease in the UK: do they persist in people with diabetes? J Epidemiol Community Health 50:137–139PubMed

22.

Wilkinson P, Sayer J, Laji K et al (1996) Comparison of case fatality in south Asian and white patients after acute myocardial infarction: observational study. BMJ 312:1330–1333PubMed

23.

McKeigue PM, Miller GJ, Marmot MG (1989) Coronary heart disease in South Asians overseas—review. J Clin Epidemiol 422:597–609CrossRef

24.

Shaukat N, DeBono DP, Jones DR (1994) A comparison of risk factors in south Asian and north European coronary artery patients with their young male offspring. Br Heart J 71:27

25.

Hughes LO, Raval U, Raftery EB (1989) First myocardial infarctions in Asian and white men. BMJ 298:1345–1350PubMed

26.

Lowry PJ, Glover DR, Mace PJ, Littler WA (1984) Coronary artery disease in Asians in Birmingham. Br Heart J 52:610–613PubMed

27.

Chadha SL, Radhakrishnan S, Ramachandran K, Kaul U, Gopinath N (1990) Epidemiological study of coronary heart disease in urban population of Delhi. Indian J Med Res 92:424–430PubMed

28.

Gupta R, Gupta VP, Ahluwalia NS (1994) Educational status, coronary heart disease, and coronary risk factor prevalence in a rural population of India. BMJ 309:1332–1336PubMed

29.

Verma NP, Mehta SP, Madhu S, Mather HM, Keen H (1986) Prevalence of known diabetes in an urban Indian environment: the Darya Ganj Diabetes Survey. Br Med J (Clin Res Ed) 293:423–424CrossRef

30.

Ramachandran A, Snehalatha C, Baskar AD et al (2004) Temporal changes in prevalence of diabetes and impaired glucose tolerance associated with lifestyle transition occurring in the rural population in India. Diabetologia 47:860–865PubMedCrossRef

31.

Ramachandran A, Snehalatha C, Kapur A et al (2001) High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 44:1094–1101PubMedCrossRef

32.

Bhopal R, Fischbacher C, Vartiainen E, Unwin N, White M, Alberti G (2005) Predicted and observed cardiovascular disease in South Asians: application of FINRISK, Framingham and SCORE models to Newcastle Heart Project data. J Public Health (Oxf) 27:93–100CrossRef

33.

Chambers JC, Wrigley J, Kooner JS (2000) Evaluation of the Joint British Societies coronary heart disease risk calculator in UK South Asians. Heart 83(Suppl):43A

34.

Aarabi M, Jackson PR (2005) Predicting coronary risk in UK South Asians: an adjustment method for Framingham-based tools. Eur J Cardiovasc Prev Rehabil 12:46–51PubMedCrossRef

35.

Ehtisham S, Crabtree N, Clark P, Shaw N, Barrett T (2005) Ethnic differences in insulin resistance and body composition in UK adolescents. J Clin Endocrinol Metab 90:3963–3969PubMedCrossRef

36.

Whincup PH, Gilg JA, Papacosta O et al (2002) Early evidence of ethnic differences in cardiovascular disease risk: cross sectional comparison of British South Asian and white children. BMJ 324:635PubMedCrossRef

37.

McTernan P, Kumar S (2004) Pathogenesis of obesity-related type 2 diabetes. In: Barnett AH, Kumar S (eds) Obesity and diabetes. Wiley, Chichester, pp 49–78CrossRef

38.

Ramachandran A, Snehalatha C, Dharmaraj D, Viswanathan M (1992) Prevalence of glucose intolerance in Asian Indians. Urban–rural difference and significance of upper body adiposity. Diabetes Care 15:1348–1355PubMedCrossRef

39.

Yajnik CS, Yudkin JS (2004) Clinical picture. The Y–Y paradox. Lancet 363:163PubMedCrossRef

40.

Working Party of the Royal College of Physicians (2004) Storing up problems: the medical cure for a slimmer nation. Royal College of Physicians, London, p 3

41.

Valsamakis G, Chetty R, Anwar A, Banerjee AK, Barnett A, Kumar S (2004) Association of simple anthropometric measures of obesity with visceral fat and the metabolic syndrome in male Caucasian and Indo-Asian subjects. Diabet Med 21:1339–1345PubMedCrossRef

42.

Krishnaveni GV, Hill JC, Veena SR et al (2005) Truncal adiposity is present at birth and in early childhood in south Indian children. Indian Pediatr 42:527–538PubMed

43.

Godfrey KM, Barker DJP (2000) Fetal nutrition and adult disease. Am J Clin Nutrition 71:1344S–1352S

44.

Dhawan J, Bray CL (1997) Asian Indians, coronary artery disease, and physical exercise. Heart 78:550–554PubMed

45.

Fischbacher CM, Hunt S, Alexander L (2004) How physically active are South Asians in the United Kingdom? A literature review. J Public Health (Oxf) 26:250–258CrossRef

46.

Cruickshank JK, Jackson SH, Bannan LT, Beevers DG, Beevers M, Osbourne VL (1983) Blood pressure in black, white and Asian factory workers in Birmingham. Postgrad Med J 59:622–626PubMedCrossRef

47.

Mather HM, Chaturvedi N, Fuller JH (1998) Mortality and morbidity from diabetes in South Asians and Europeans: 11-year follow-up of the Southall Diabetes Survey, London, UK. Diabet Med 15:53–59PubMedCrossRef

48.

Davis TM, Cull CA, Holman RR; UK Prospective Diabetes Study (UKPDS) Group (2001) Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: UK Prospective Diabetes Study (UKPDS 55). Diabetes Care 24:1167–1174PubMedCrossRef

49.

Hughes LO, Woiciechowski AP, Raftery EB (1990) Relationship between plasma cholesterol and coronary artery disease in Asians. Atherosclerosis 83:5–20CrossRef

50.

Bhatnager D, Anand IS, Durrington PN et al (1995) Coronary risk factors in people from the Indian subcontinent living in west London and their siblings in India. Lancet 345:405–409CrossRef

51.

Kulkarni KR, Markovitz JH, Nanda NC, Segrest JP (1999) Increased prevalence of smaller and denser LDL particles in Asian Indians. Arterioscler Thromb Vasc Biol 19:2749–2755PubMed

52.

National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106:3143–3421

53.

Misra A, Vikram NK, Arya S et al (1998) Lipoprotein(a) is an independent risk factor for coronary artery disease in NIDDM patients in South India. Diabetes Care 21:1819–1823CrossRef

54.

Shaukat N, de Bono DP, Jones DR (1995) Like father like son? Sons of patients of European or Indian origin with coronary artery disease reflect their parents’ risk factor patterns. Br Heart J 74:318–323PubMed

55.

Anonymous (1991) Lipoprotein (a). Lancet 337:397–398CrossRef

56.

Ridker PM (2001) High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103:1813–1818PubMed

57.

Chambers JC, Eda S, Bassett P et al (2001) C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation 104:145–150PubMed

58.

Forouhi NG, Sattar N, McKeigue PM (2001) Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord 25:1327–1331PubMedCrossRef

59.

Cook DG, Mendall MA, Whincup PH et al (2000) C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis 149:139–150PubMedCrossRef

60.

Mohan V, Deepa R, Pradeepa R et al (2005) Association of low adiponectin levels with the metabolic syndrome—the Chennai Urban Rural Epidemiology Study (CURES-4). Metabolism 54:476–481PubMedCrossRef

61.

Snehalatha C, Mukesh B, Simon M, Viswanathan V, Haffner SM, Ramachandran A (2003) Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians. Diabetes Care 26:3226–3229PubMedCrossRef

62.

Valsamakis G, Chetty R, McTernan PG, Al-Daghri NM, Barnett AH, Kumar S (2003) Fasting serum adiponectin concentration is reduced in Indo-Asian subjects and is related to HDL cholesterol. Diabetes Obes Metab 5:131–135PubMedCrossRef

63.

Chambers JC, McGregor A, Jean-Marie J, Kooner JS (1999) Abnormalities of vascular endothelial function may contribute to increased coronary heart disease risk in UK Indian Asians. Heart 81:501–504PubMed

64.

Kain K, Catto AJ, Grant PJ (2001) Impaired fibrinolysis and increased fibrinogen levels in South Asian subjects. Atherosclerosis 156:457–461PubMedCrossRef

65.

Nagi DK, Mohamed Ali V, Jain SK, Walji S, Yudkin JS (1996) Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians. Diabet Med 13:59–64PubMedCrossRef

66.

Deepa R, Velmurugan K, Saravanan G, Karkuzhali K, Dwarakanath V, Mohan V (2001) Absence of association between serum homocysteine levels and coronary artery disease in south Indian males. Indian Heart J 53:44–47PubMed

67.

Chambers JC, Obeid OA, Refsum H et al (2000) Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet 355:523–527PubMedCrossRef

68.

Boucher BJ, Mannan N, Noonan K, Hales CN, Evans SJ (1995) Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia 38:1239–1245PubMedCrossRef

69.

Pittas AG, Li T, Willett WC, Manson JE, Dawson-Hughes B, Hu FB (2005) A prospective study of vitamin D intake and risk of type 2 diabetes in women. Presented at: American Diabetes Association 65th Scientific Session; June 10–14, San Diego, CA: 1772P (Abstract)

70.

Ramachandran A, Snehalatha C, Latha E, Satyavani K, Vijay V (1998) Clustering of cardiovascular risk factors in urban Asian Indians. Diabetes Care 21:967–971PubMedCrossRef

71.

Tillin T, Forouhi N, Johnston DG, McKeigue PM, Chaturvedi N, Godsland IF (2005) Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study. Diabetologia 48:649–656PubMedCrossRef

72.

International Diabetes Federation (2005) The IDF consensus worldwide definition of the metabolic syndrome. Available from http://www.idf.org, last accessed May 2006

73.

Kahn R, Buse J, Ferrannini E, Stern M (2005) The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28:2289–2304PubMedCrossRef

74.

Gale EAM (2005) The myth of the metabolic syndrome. Diabetologia 48:1679–1683PubMedCrossRef

75.

Abate N, Carulli L, Cabo-Chan A, Chandalia M, Snell PG, Grundy SM (2003) Genetic polymorphism PC-1 K121Q and the ethnic susceptibility to insulin resistance. J Clin Endocrinol Metab 88:5927–5934PubMedCrossRef

76.

Yusuf S, Hawken S, Ounpuu S (2004) Effects of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet 364:937–952PubMedCrossRef

77.

Gupta R, Singhal S (1997) Coronary heart disease in India. Circulation 96:3785PubMed

78.

Patel JV, Vyas A, Cruickshank JK et al (2006) Impact of migration on coronary heart disease risk factors: comparison of Gujaratis in Britain and their contemporaries in villages of origin in India. Atherosclerosis 185:297–306PubMedCrossRef

79.

Nath BS, Murthy MK (1988) Cholesterol in Indian ghee. Lancet 2:39PubMedCrossRef

80.

Jacobson MS (1987) Cholesterol oxides in Indian ghee: possible cause of unexplained high risk of atherosclerosis in Indian immigrant populations. Lancet 2:656–658PubMedCrossRef

81.

Singh RB, Mori H, Chen J et al (1996) Recommendations for the prevention of coronary artery disease in Asians: a scientific statement of the International College of Nutrition. J Cardiovasc Risk 3:489–494PubMedCrossRef

82.

Bhalodkar NC, Blum S, Rana T, Bhalodkar A, Kitchappa R, Enas EA (2005) Effect of leisure time exercise on high-density lipoprotein cholesterol, its subclasses, and size in Asian Indians. Am J Cardiol 96:98–100PubMedCrossRef

83.

McKeigue P (2000) Development of interventions to reduce the risk of CHD in South Asians (WE1). The Research Findings Register. Summary number 116. Available from http://www.ReFeR.nhs.uk, last accessed May 2006

84.

Heart Protection Study Collaborative Group (2003) MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361:2005–2016CrossRef

85.

Colhoun HM, Betteridge DJ, Durrington PN et al (2004) Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364:685–696PubMedCrossRef

86.

Lawrence IG, McNally PG (2001) Heart disease in Asian people with diabetes. Practical Diabetes Int 18:192–196CrossRef

87.

Rubins HB, Robins SJ, Collins D et al (1999) Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. N Engl J Med 341:410–418PubMedCrossRef

88.

FIELD Study Investigators (2005) Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD Study): randomised controlled trial. Lancet 366:1849–1861CrossRef

89.

Kashyap ML, McGovern ME, Berra K et al (2002) Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia. Am J Cardiol 89:672–678PubMedCrossRef

90.

Brown BG, Zhao XQ, Chait A et al (2001) Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 345:1583–1592PubMedCrossRef

91.

Hansson L, Zanchetti A, Carruthers SG et al (1998) Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 351:1755–1762PubMedCrossRef

92.

Diabetes UK (2001) Aspirin treatment in diabetes. Available from http://www.diabetes.org.uk/infocentre/carerec/aspirin.htm, last accessed May 2006

93.

Ford S, Mai F, Manson A, Rukin N, Dunne F (2000) Diabetes knowledge—are patients getting the message? Int J Clin Pract 54:535–536PubMed

94.

Hawthorne K (2001) Effect of culturally appropriate health education on glycaemic control and knowledge of diabetes in British Pakistani women with type 2 diabetes mellitus. Health Educ Res 16:373–381PubMedCrossRef

95.

Rankin J, Bhopal R (2001) Understanding of heart disease and diabetes in a South Asian community: cross-sectional study testing the ‘snowball’ sample method. Public Health 115:253–260PubMed

96.

Vyas A, Haidery AZ, Wiles PG, Gill S, Roberts C, Cruickshank JK (2003) A pilot randomized trial in primary care to investigate and improve knowledge, awareness and self-management among South Asians with diabetes in Manchester. Diabet Med 20:1022–1026PubMedCrossRef

97.

Patel MG, Wright DJ, Gill PS, Jerwood D, Silcok J, Chrystyn H (2002) Prescribing of lipid lowering drugs so South Asian patients: ecological study. BMJ 325:25–26PubMedCrossRef

98.

O’Hare JP, Raymond NT, Mughal S et al (2004) Evaluation of delivery of enhanced diabetes care to patients of South Asian ethnicity: the United Kingdom Asian Diabetes Study (UKADS). Diabetic Med 21:1357–1365PubMedCrossRef

99.

Ward PR, Noyce PR, St Leger AS (2005) Multivariate regression analysis of associations between general practitioner prescribing rates for coronary heart disease drugs and healthcare needs indicators. J Epidemiol Community Health 59:86PubMed

100.

Cruikshank K, Pickup J, Williams G, (eds) (1997) Textbook of diabetes, vol 1, 2nd edn. Blackwell Science, Oxford, p 3.21

Titel: Type 2 diabetes and cardiovascular risk in the UK south Asian community
verfasst von: A. H. Barnett
A. N. Dixon
S. Bellary
M. W. Hanif
J. P. O’Hare
N. T. Raymond
S. Kumar
Publikationsdatum: 01.10.2006
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 10/2006
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-006-0325-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2006

Insulin modulates the secretion of proteins from mature 3T3-L1 adipocytes: a role for transcriptional regulation of processing

BCL-6: a possible missing link for anti-inflammatory PPAR-δ signalling in pancreatic beta cells

High glucose and homocysteine synergistically affect the metalloproteinases–tissue inhibitors of metalloproteinases pattern, but not TGFB expression, in human fibroblasts

Peroxisome proliferator-activated receptor-γ coactivator-1 and insulin resistance: acute effect of fatty acids

Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes